Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ORM-5029 |
Trade Name | |
Synonyms | ORM 5029|ORM5029 |
Drug Descriptions |
ORM-5029 is an antibody neodegrader conjugate comprising a GSPT1 degrader linked to pertuzumab, which may lead to growth inhibition of ERBB2 (HER2)-positive tumor cells, and decreased tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 3933). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ORM-5029 | ORM-5029 | 0 | 1 |